A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2019; you can also visit the original URL.
The file type is application/pdf.
Reply to Gelfand et al and Solla
2013
Clinical Infectious Diseases
Preserved Fulltext
TO THE EDITOR-We appreciate the interest Gelfand et al [1] have shown regarding our observational, nonrandomized, comparative multicenter study [2] . Infective endocarditis (IE) is an uncommon, severe disease [3], and it is inevitable that randomized trials on this condition are lacking. In our observational study, the combination of ampicillin and ceftriaxone (AC) was compared with the standard-of-care ampicillin and gentamicin combination (AG) for treating Enterococcus faecalis IE, but other comparisons
doi:10.1093/cid/cit331
pmid:23704124
fatcat:fitotxyo3fgbhgynhg75mdsnim